ERBB2 and glioblastoma: These compounds decreased HER-2 and phospho-Akt cellular expression and suppressed the proliferation of TMZ-sensitive and TMZ-resistant glioblastoma cells while also promoting the decline of tumor growth in a mouse glioblastoma model.